263 related articles for article (PubMed ID: 23263355)
1. Effects of idebenone on color vision in patients with leber hereditary optic neuropathy.
Rudolph G; Dimitriadis K; Büchner B; Heck S; Al-Tamami J; Seidensticker F; Rummey C; Leinonen M; Meier T; Klopstock T
J Neuroophthalmol; 2013 Mar; 33(1):30-6. PubMed ID: 23263355
[TBL] [Abstract][Full Text] [Related]
2. Visual function in chronic Leber's hereditary optic neuropathy during idebenone treatment initiated 5 to 50 years after onset.
Pemp B; Kircher K; Reitner A
Graefes Arch Clin Exp Ophthalmol; 2019 Dec; 257(12):2751-2757. PubMed ID: 31482278
[TBL] [Abstract][Full Text] [Related]
3. Real-World Clinical Experience With Idebenone in the Treatment of Leber Hereditary Optic Neuropathy.
Catarino CB; von Livonius B; Priglinger C; Banik R; Matloob S; Tamhankar MA; Castillo L; Friedburg C; Halfpenny CA; Lincoln JA; Traber GL; Acaroglu G; Black GCM; Doncel C; Fraser CL; Jakubaszko J; Landau K; Langenegger SJ; Muñoz-Negrete FJ; Newman NJ; Poulton J; Scoppettuolo E; Subramanian P; Toosy AT; Vidal M; Vincent AL; Votruba M; Zarowski M; Zermansky A; Lob F; Rudolph G; Mikazans O; Silva M; Llòria X; Metz G; Klopstock T
J Neuroophthalmol; 2020 Dec; 40(4):558-565. PubMed ID: 32991388
[TBL] [Abstract][Full Text] [Related]
4. A randomized placebo-controlled trial of idebenone in Leber's hereditary optic neuropathy.
Klopstock T; Yu-Wai-Man P; Dimitriadis K; Rouleau J; Heck S; Bailie M; Atawan A; Chattopadhyay S; Schubert M; Garip A; Kernt M; Petraki D; Rummey C; Leinonen M; Metz G; Griffiths PG; Meier T; Chinnery PF
Brain; 2011 Sep; 134(Pt 9):2677-86. PubMed ID: 21788663
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic Effects of Idebenone on Leber Hereditary Optic Neuropathy.
Zhao X; Zhang Y; Lu L; Yang H
Curr Eye Res; 2020 Oct; 45(10):1315-1323. PubMed ID: 32111141
[No Abstract] [Full Text] [Related]
6. Visual prognosis better in eyes with less severe reduction of visual acuity one year after onset of Leber hereditary optic neuropathy caused by the 11,778 mutation.
Mashima Y; Kigasawa K; Shinoda K; Wakakura M; Oguchi Y
BMC Ophthalmol; 2017 Oct; 17(1):192. PubMed ID: 29047345
[TBL] [Abstract][Full Text] [Related]
7. [Raxone in the Leber optical neuropathy: Parisian experience].
Orssaud C; Bidot S; Lamirel C; Brémond Gignac D; Touitou V; Vignal C
J Fr Ophtalmol; 2019 Mar; 42(3):269-275. PubMed ID: 30712826
[TBL] [Abstract][Full Text] [Related]
8. Idebenone for Leber's hereditary optic neuropathy.
Gueven N
Drugs Today (Barc); 2016 Mar; 52(3):173-81. PubMed ID: 27186591
[TBL] [Abstract][Full Text] [Related]
9. Idebenone: A Review in Leber's Hereditary Optic Neuropathy.
Lyseng-Williamson KA
Drugs; 2016 May; 76(7):805-13. PubMed ID: 27071925
[TBL] [Abstract][Full Text] [Related]
10. Idebenone protects against retinal damage and loss of vision in a mouse model of Leber's hereditary optic neuropathy.
Heitz FD; Erb M; Anklin C; Robay D; Pernet V; Gueven N
PLoS One; 2012; 7(9):e45182. PubMed ID: 23028832
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of Japanese patients with Leber's hereditary optic neuropathy and idebenone trial: a prospective, interventional, non-comparative study.
Ishikawa H; Masuda Y; Ishikawa H; Shikisima K; Goseki T; Kezuka T; Terao M; Miyazaki A; Matsumoto K; Nishikawa H; Gomi F; Mimura O
Jpn J Ophthalmol; 2021 Jan; 65(1):133-142. PubMed ID: 33185792
[TBL] [Abstract][Full Text] [Related]
12. Altering neuronal circuitry with 4-aminopyridine for visual improvement in Leber's hereditary optic neuropathy (LHON).
Chan JW; Sultan W; Karanjia R; Sadun AA
Mitochondrion; 2022 Jan; 62():181-186. PubMed ID: 34915201
[TBL] [Abstract][Full Text] [Related]
13. Genetic variants affecting NQO1 protein levels impact the efficacy of idebenone treatment in Leber hereditary optic neuropathy.
Aleo SJ; Del Dotto V; Romagnoli M; Fiorini C; Capirossi G; Peron C; Maresca A; Caporali L; Capristo M; Tropeano CV; Zanna C; Ross-Cisneros FN; Sadun AA; Pignataro MG; Giordano C; Fasano C; Cavaliere A; Porcelli AM; Tioli G; Musiani F; Catania A; Lamperti C; Marzoli SB; De Negri A; Cascavilla ML; Battista M; Barboni P; Carbonelli M; Amore G; La Morgia C; Smirnov D; Vasilescu C; Farzeen A; Blickhaeuser B; Prokisch H; Priglinger C; Livonius B; Catarino CB; Klopstock T; Tiranti V; Carelli V; Ghelli AM
Cell Rep Med; 2024 Feb; 5(2):101383. PubMed ID: 38272025
[TBL] [Abstract][Full Text] [Related]
14. Is Leber hereditary optic neuropathy treatable? Encouraging results with idebenone in both prospective and retrospective trials and an illustrative case.
Sabet-Peyman EJ; Khaderi KR; Sadun AA
J Neuroophthalmol; 2012 Mar; 32(1):54-7. PubMed ID: 22269948
[TBL] [Abstract][Full Text] [Related]
15. Male prevalence of acquired color vision defects in asymptomatic carriers of Leber's hereditary optic neuropathy.
Ventura DF; Gualtieri M; Oliveira AG; Costa MF; Quiros P; Sadun F; de Negri AM; Salomão SR; Berezovsky A; Sherman J; Sadun AA; Carelli V
Invest Ophthalmol Vis Sci; 2007 May; 48(5):2362-70. PubMed ID: 17460303
[TBL] [Abstract][Full Text] [Related]
16. Do idebenone and vitamin therapy shorten the time to achieve visual recovery in Leber hereditary optic neuropathy?
Mashima Y; Kigasawa K; Wakakura M; Oguchi Y
J Neuroophthalmol; 2000 Sep; 20(3):166-70. PubMed ID: 11001192
[TBL] [Abstract][Full Text] [Related]
17. Idebenone (Raxone°) and Leber hereditary optic neuropathy.
Prescrire Int; 2017 Feb; 26(179):41. PubMed ID: 30726629
[No Abstract] [Full Text] [Related]
18. Novel use of idebenone in Leber's hereditary optic neuropathy in Hong Kong.
Cheng SW; Ko CH; Yau SK; Mak C; Yuen YF; Lee CY
Hong Kong Med J; 2014 Oct; 20(5):451-4. PubMed ID: 25307075
[TBL] [Abstract][Full Text] [Related]
19. Persistence of the treatment effect of idebenone in Leber's hereditary optic neuropathy.
Klopstock T; Metz G; Yu-Wai-Man P; Büchner B; Gallenmüller C; Bailie M; Nwali N; Griffiths PG; von Livonius B; Reznicek L; Rouleau J; Coppard N; Meier T; Chinnery PF
Brain; 2013 Feb; 136(Pt 2):e230. PubMed ID: 23388409
[No Abstract] [Full Text] [Related]
20. [Response to idebenone and multivitamin therapy in Leber's hereditary optic neuropathy].
Barnils N; Mesa E; Muñoz S; Ferrer-Artola A; Arruga J
Arch Soc Esp Oftalmol; 2007 Jun; 82(6):377-80. PubMed ID: 17573650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
